These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
511 related articles for article (PubMed ID: 33795384)
1. Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy. Shin DH; Nguyen T; Ozpolat B; Lang F; Alonso M; Gomez-Manzano C; Fueyo J J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795384 [TBL] [Abstract][Full Text] [Related]
10. Role of NK cells in immunotherapy and virotherapy of solid tumors. Cantoni C; Grauwet K; Pietra G; Parodi M; Mingari MC; De Maria A; Favoreel H; Vitale M Immunotherapy; 2015; 7(8):861-82. PubMed ID: 26314197 [TBL] [Abstract][Full Text] [Related]
11. Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study. Marchini A; Daeffler L; Pozdeev VI; Angelova A; Rommelaere J Front Immunol; 2019; 10():1848. PubMed ID: 31440242 [TBL] [Abstract][Full Text] [Related]
12. [Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer]. Kochneva GV; Sivolobova GF; Tkacheva AV; Gorchakov AA; Kulemzin SV Mol Biol (Mosk); 2020; 54(1):3-16. PubMed ID: 32163385 [TBL] [Abstract][Full Text] [Related]
14. Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells. Osali A; Zhiani M; Ghaebi M; Meymanat M; Esmaeilzadeh A Pharmacol Res; 2020 Nov; 161():105094. PubMed ID: 32795509 [TBL] [Abstract][Full Text] [Related]
15. Oncolytic virotherapy as immunotherapy. Melcher A; Harrington K; Vile R Science; 2021 Dec; 374(6573):1325-1326. PubMed ID: 34882456 [TBL] [Abstract][Full Text] [Related]
16. Immune landscape and response to oncolytic virus-based immunotherapy. Lin C; Teng W; Tian Y; Li S; Xia N; Huang C Front Med; 2024 Jun; 18(3):411-429. PubMed ID: 38453818 [TBL] [Abstract][Full Text] [Related]
17. Oncolytic Viral Therapy and the Immune System: A Double-Edged Sword Against Cancer. Marelli G; Howells A; Lemoine NR; Wang Y Front Immunol; 2018; 9():866. PubMed ID: 29755464 [TBL] [Abstract][Full Text] [Related]
18. Oncolytic viruses for cancer immunotherapy. Hemminki O; Dos Santos JM; Hemminki A J Hematol Oncol; 2020 Jun; 13(1):84. PubMed ID: 32600470 [TBL] [Abstract][Full Text] [Related]
19. Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue. Das K; Urbiola C; Spiesschaert B; Mueller P; Wollmann G Methods Mol Biol; 2020; 2058():155-177. PubMed ID: 31486037 [TBL] [Abstract][Full Text] [Related]
20. The Multifaceted Role of Macrophages in Oncolytic Virotherapy. Hofman L; Lawler SE; Lamfers MLM Viruses; 2021 Aug; 13(8):. PubMed ID: 34452439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]